Skinvisible Web Sign Up for Updates         T 702.433.7154   |   F 702.433.7192
Skinvisible - Polymer Delivery System

The Ultimate Polymer Delivery System.
April 30, 2004

Skinvisible(R) Launches New UV Free Sunless Tanning Product Line 'Solerra(TM)' Into Billion Dollar Market

LAS VEGAS, Apr 30, 2004 (Canada NewsWire via COMTEX) --

Skinvisible, Inc. (OTC Bulletin Board: SKVI) through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc. announces the launch of its newly formulated Solerra(TM) Skincare line of products for the Sunless Tanning market at 2004 International Esthetics, Cosmetics &Spa Conference in Las Vegas, May 1.

When it comes to Sunless Tanners, a natural-looking, long-lasting tan is the ideal result. To meet this challenge, Skinvisible(R) has undertaken extensive laboratory testing to create Solerra(TM) Skincare, comprising a line of unique Sunless Tanning Products that ensure consistent color with longer-lasting results and no unattractive streaking.

'It's been a year in the making, however when we first saw Sunless Tanning Products we knew that our polymer technology could have a positive impact in this growing market,'says Skinvisible(R) President Terry Howlett. Industry sales of Sunless Tanning Products are projected to exceed $1 billion in the US alone this year with higher sales projected in Europe.

Skinvisible(R) Chemist, Dr. James Roszell explains, 'When topically applied, Solerra's(TM) UV-free tanning formulations with Invisicare(R) adhere to the skin's outer layer, forming a bond that holds the active ingredient DHA on the skin while ensuring a natural looking tan that will last for seven to ten days. Enriched with Vitamin E and natural oils, Solerra's(TM) Sunless Tanning Products provide the additional benefits of a quick drying and odorless application. 'The properties of Invisicare(R) also allow the skin to breathe, a distinct advantage over other emollients such as petrolatum, silicone, alcohol and wax that have been known to clog pores and dry the skin,'adds Dr. Roszell.

Other products encompassed within the Solerra(TM) Skincare line include daily moisturizers, sunscreens with SPF, and sunless tanning enhancers. 'The public's renewed interest in self tanning, free from the damaging UV rays of the sun, has created the necessity to raise the bar in this rapidly growing industry,'says Skinvisible(R) Sales &Marketing Manager Jerry Burke. 'And where else can you get a just been to Hawaii looking tan in only 5 minutes.'

Solerra(TM) Skincare products are also available to spas and tanning salons as an Airbrush Sunless Tanning Spray. 'One of the problems when I first started in the airbrush tanning industry was that I couldn't find a lab that produced a quality DHA formulation. Solerra's(TM) strength is in its state-of-the-art polymer technology,'advises Jody Only, President of Airbrushed Body's of Charleston, South Carolina and a Solerra(TM) distributor.

For further information on Solerra(TM) Skincare products and distributor opportunities in the US and Internationally contact Jerry Burke, toll-free at 877.925.6000 or 702.433.7154 (sales@solerra.com) or visit (www.solerra.com).

Headquartered in Las Vegas, Nevada, Skinvisible, Inc. is focused on the development of innovative topical polymer-based delivery systems and related technologies incorporating its patent-pending formula/process for combining hydrophilic and hydrophobic polymers into stable water emulsions. Skinvisible's(R) primary marketing and sales objectives are to license its technologies and/or sell its delivery systems to provide enhanced product performance for established brand manufacturers and providers of prescription, over-the-counter, cosmetic, and skincare products. In addition Skinvisible(R) formulates and manufactures products for private label customers.

This press release contains 'forward looking'statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934 as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports that will be on file with the US Securities and Exchange Commission (including but not limited to the report on Form 10-KSB for the year ending December 31, 2003).

For further information, please contact T. Howlett of Skinvisible, Inc., +1-702-433-7154, or fax, +1-702-433-7192, terry@skinvisible.com; or Media, Tommi Hanley of Thompson Lloyd Communications, +1-250-860-9959, tommi.tlc@shaw.ca, for Skinvisible, Inc.
  Press Release Index
New Press Release Alerts:


Click here to join our mailing list.
Home    |     About us    |    Technology    |    Products    |    Investors    |    Contact Us    |    Disclaimer & Privacy    |     Sign Up for Updates
© 2008 Skinvisible Pharmaceuticals, Inc.     Note: This website is not intended for Canadian residents.